Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells
- 297 Downloads
There is growing evidence on the role of ocular renin–angiotensin system (RAS) in the development of diabetic retinopathy (DR), particularly due to the trigger of oxidative stress and angiogenesis. Despite this there is no effective RAS-based therapy in DR capable of preventing retinal damage induced by RAS activation. We recently described that retinal pigment epithelium (RPE) cells express the main components of the RAS. We here propose to investigate the role of glucose upon the retinal RAS and whether aliskiren, a direct renin inhibitor, protects RPE cells from angiogenesis and oxidative stress. RPE cells were chosen as target since one of the first events in DR is the dysfunction of the RPE retinal layer, which as a key function in maintaining the integrity of the retina. We found that the RAS present in the RPE cells was deregulated by hyperglycemic glucose concentrations. Exposure of RPE cells to angiotensin II increased the levels of the main pro-angiogenic factor, vascular endothelial growth factor (VEGF) in a concentration-dependent manner. Additionally, angiotensin II also stimulated the production of reactive oxygen species in RPE cells. Treatment of RPE cells with aliskiren decreased the levels of oxidative stress and promoted the expression of anti-angiogenic factors such as the pigment epithelium-derived factor and the VEGF165b isoform. Our findings demonstrate that the RAS is deregulated in hyperglycemic conditions and that aliskiren successfully protected RPE cells from RAS over activation. These anti-angiogenic and antioxidant properties described for aliskiren over RPE cells suggest that this drug has potential to be used in the treatment of diabetic retinopathy.
KeywordsRetinal pigment epithelium Aliskiren Renin–angiotensin system Angiogenesis Oxidative stress
Angiotensin II-converting enzyme
Angiotensin II receptor blocker
Blood retinal barrier
Direct renin inhibitor
Pigment epithelium-derived factor
Reactive oxygen species
Retinal pigment epithelium
Vascular endothelial growth factor
This work was supported by the Portuguese Foundation for Science and Technology (FCT) with an individual grant to S Simão (SFRH/BPD/78404/2011), DF Santos (PD/BD/114251/2016) and GA Silva (EXPL-BIM-MEC-1433-2013), Research Center Grant UID/BIM/04773/2013 (CBMR), iNOVA4Health-UID/Multi/04462/2013, a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement. Also acknowledged is PIRG05-GA-2009-249314–EyeSee (Grant to GA Silva).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Simão S, Bitoque DB, Calado SM, Silva GA (2016) Oxidative stress modulates the expression of VEGF isoforms in the diabetic retina. New Frontiers Ophthalmol 2(1):77–83Google Scholar
- 24.Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64(21):7822–7835CrossRefPubMedGoogle Scholar